Neuronetics STIM Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $151.64M+1.7% | $149.16M+14.8% | $129.87M+16.9% | $111.11M+24.2% | $89.45M+19.4% | ||
| $78.91M+2.7% | $76.85M+19.4% | $64.38M+32.1% | $48.72M+49.3% | $32.64M+57.4% | ||
| $72.72M+0.6% | $72.31M+10.4% | $65.5M+5.0% | $62.39M+9.8% | $56.81M+4.9% | ||
| 48%-0.5pp | 48.5%-2.0pp | 50.4%-5.7pp | 56.2%-7.4pp | 63.5%-8.8pp | ||
| $6.33M-3.8% | $6.58M-38.4% | $10.69M-7.9% | $11.6M-3.6% | $12.04M-5.7% | ||
| $46.2M-2.7% | $47.46M+4.2% | $45.53M-0.1% | $45.56M-0.9% | $45.99M+0.8% | ||
| $49.61M-0.2% | $49.7M+5.4% | $47.15M+8.4% | $43.51M+16.0% | $37.5M+23.7% | ||
| $102.14M-1.5% | $103.74M+0.4% | $103.36M+2.7% | $100.66M+5.4% | $95.53M+7.7% | ||
| $102.14M-1.5% | $103.74M+0.4% | $103.36M+2.7% | $100.66M+5.4% | $95.53M+7.7% | ||
| -$29.42M+6.4% | -$31.44M+17.0% | -$37.87M+1.1% | -$38.27M+1.2% | -$38.72M-12.0% | ||
| -19.4%+1.7pp | -21.1%+8.1pp | -29.2%+5.3pp | -34.4%+8.8pp | -43.3%+2.9pp | ||
| $8.76M+4.1% | $8.42M+7.1% | $7.85M+6.5% | $7.37M-0.1% | $7.38M+1.3% | ||
| $1.49M+108% | $716K-35.4% | $1.11M-27.1% | $1.52M-23.4% | $1.99M-22.1% | ||
| —— | —— | —— | —— | —— | ||
| -$37.11M+4.8% | -$39M+12.4% | -$44.5M+8.8% | -$48.8M-0.6% | -$48.51M-11.0% | ||
| -24.5%+1.7pp | -26.1%+8.1pp | -34.3%+9.7pp | -43.9%+10.3pp | -54.2%+4.1pp | ||
| -$0.54+8.5% | -$0.59+28.9% | -$0.83+27.2% | -$1.14+13.6% | -$1.32+4.3% | ||
| -$0.54+8.5% | -$0.59+28.9% | -$0.83+27.2% | -$1.14+13.6% | -$1.32+4.3% | ||
| 269M+3.1% | 260.9M+15.1% | 226.7M+19.5% | 189.6M+23.5% | 153.5M+26.3% | ||
| 269M+3.1% | 260.9M+15.1% | 226.7M+19.5% | 189.6M+23.5% | 153.5M+26.3% | ||
| $1.49M+108% | $716K-35.4% | $1.11M-27.1% | $1.52M-23.4% | $1.99M-22.1% | ||
| $151.64M+1.7% | $149.16M+14.8% | $129.87M+16.9% | $111.11M+24.2% | $89.45M+19.4% | ||
| -$29.42M+6.4% | -$31.44M+17.0% | -$37.87M+1.1% | -$38.27M+1.2% | -$38.72M-12.0% | ||
| -$26.12M+6.6% | -$27.97M+19.4% | -$34.72M+2.2% | -$35.5M+2.2% | -$36.3M-11.7% | ||
| -$26.12M+6.6% | -$27.97M+19.4% | -$34.72M+2.2% | -$35.5M+2.2% | -$36.3M-11.7% | ||
| -17.2%+1.5pp | -18.8%+8.0pp | -26.7%+5.2pp | -32%+8.6pp | -40.6%+2.8pp | ||
| -$29.42M+6.4% | -$31.44M+17.0% | -$37.87M+1.1% | -$38.27M+1.2% | -$38.72M-12.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Neuronetics's revenue?
- Neuronetics (STIM) generated $151.6M in revenue over the trailing twelve months, up 69.5% year over year.
- Is Neuronetics profitable?
- Neuronetics is not currently profitable: it reported a net loss of $37.1M over the trailing twelve months, a -24.5% net margin.
- What are Neuronetics's profit margins?
- Gross margin is 48.0% and operating margin is -19.4%, with a -24.5% net margin.
- What is Neuronetics's earnings per share?
- Neuronetics's diluted EPS over the trailing twelve months is $-0.54.
- Where does Neuronetics's income statement data come from?
- Every line is extracted from Neuronetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
